Skip to main content

Clinical trial MO29112

A multi-centre randomized clinical trial of Biomarker-Driven maintenance treatment for first-line metastatic colorectal cancer (MODUL)

Cancers
Organ Colon
Trial status Trial closed
Investigator
Trial type
Interventional with experimental drug
Phase Trial phase 2
Academic trial Non
Sponsor Roche
EudraCT Identifier 2014-001017-61
ClinicalTrials.gov https://clinicaltrials.gov/ct2/show/NCT02291289
Inclusion criteria first line RECIST 1.1
Last update